These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


592 related items for PubMed ID: 21822558

  • 1. Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin.
    Yu MC, Lee YS, Lin SE, Wu HY, Chen TC, Lee WC, Chen MF, Tsai CN.
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S455-63. PubMed ID: 21822558
    [Abstract] [Full Text] [Related]

  • 2. Integrated analysis of prognostic gene expression profiles from hepatitis B virus-positive hepatocellular carcinoma and adjacent liver tissue.
    Kim BY, Suh KS, Lee JG, Woo SR, Park IC, Park SH, Han CJ, Kim SB, Jeong SH, Yeom YI, Yang SJ, Kim CM, Cho SJ, Yoo YD, Cho MH, Jang JJ, Choi DW, Lee KH.
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S328-38. PubMed ID: 21533656
    [Abstract] [Full Text] [Related]

  • 3. Prognostic significance of osteopontin in hepatitis B virus-related hepatocellular carcinoma.
    Xie H, Song J, Du R, Liu K, Wang J, Tang H, Bai F, Liang J, Lin T, Liu J, Fan D.
    Dig Liver Dis; 2007 Feb; 39(2):167-72. PubMed ID: 17161983
    [Abstract] [Full Text] [Related]

  • 4. Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma.
    Woo HG, Park ES, Cheon JH, Kim JH, Lee JS, Park BJ, Kim W, Park SC, Chung YJ, Kim BG, Yoon JH, Lee HS, Kim CY, Yi NJ, Suh KS, Lee KU, Chu IS, Roskams T, Thorgeirsson SS, Kim YJ.
    Clin Cancer Res; 2008 Apr 01; 14(7):2056-64. PubMed ID: 18381945
    [Abstract] [Full Text] [Related]

  • 5. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
    Kim MY, Park E, Park JH, Park DH, Moon WS, Cho BH, Shin HS, Kim DG.
    Oncogene; 2001 Jul 27; 20(33):4568-75. PubMed ID: 11494152
    [Abstract] [Full Text] [Related]

  • 6. [CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy].
    Wang ZS, Wu LQ, Yi X, Geng C, Li YJ, Yao RY, Hu WY, Han B.
    Zhonghua Zhong Liu Za Zhi; 2012 Oct 27; 34(10):753-8. PubMed ID: 23291069
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
    Pan HW, Ou YH, Peng SY, Liu SH, Lai PL, Lee PH, Sheu JC, Chen CL, Hsu HC.
    Cancer; 2003 Jul 01; 98(1):119-27. PubMed ID: 12833464
    [Abstract] [Full Text] [Related]

  • 8. Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling.
    Ueda T, Honda M, Horimoto K, Aburatani S, Saito S, Yamashita T, Sakai Y, Nakamura M, Takatori H, Sunagozaka H, Kaneko S.
    Genomics; 2013 Apr 01; 101(4):238-48. PubMed ID: 23485556
    [Abstract] [Full Text] [Related]

  • 9. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
    Llovet JM, Chen Y, Wurmbach E, Roayaie S, Fiel MI, Schwartz M, Thung SN, Khitrov G, Zhang W, Villanueva A, Battiston C, Mazzaferro V, Bruix J, Waxman S, Friedman SL.
    Gastroenterology; 2006 Dec 01; 131(6):1758-67. PubMed ID: 17087938
    [Abstract] [Full Text] [Related]

  • 10. [Expression and clinical significance of metastasis-associated in colon cancer 1 (MACC1) in HBV-related hepatocellular carcinoma].
    Chang XJ, Wang CP, Qu JH, Lu YY, Chen Y, Bai WL, Gao XD, Hao LY, Xu GL, Wang H, Yang YP.
    Zhonghua Zhong Liu Za Zhi; 2012 Oct 01; 34(10):748-52. PubMed ID: 23291068
    [Abstract] [Full Text] [Related]

  • 11. Wnt-1 protein as a prognostic biomarker for hepatitis B-related and hepatitis C-related hepatocellular carcinoma after surgery.
    Lee HH, Uen YH, Tian YF, Sun CS, Sheu MJ, Kuo HT, Koay LB, Lin CY, Tzeng CC, Cheng CJ, Tang LY, Tsai SL, Wang AH.
    Cancer Epidemiol Biomarkers Prev; 2009 May 01; 18(5):1562-9. PubMed ID: 19423534
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P, Jin J, Liao Y, Li J, Yu XZ, Liao W, He S.
    Oncotarget; 2015 Dec 01; 6(38):41383-97. PubMed ID: 26515591
    [Abstract] [Full Text] [Related]

  • 14. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
    Jin YJ, Shim JH, Lee HC, Yoo DJ, Kim KM, Lim YS, Suh DJ.
    J Gastroenterol Hepatol; 2011 Sep 01; 26(9):1380-8. PubMed ID: 21884247
    [Abstract] [Full Text] [Related]

  • 15. Expression of glypican 3 enriches hepatocellular carcinoma development-related genes and associates with carcinogenesis in cirrhotic livers.
    Liu X, Wang SK, Zhang K, Zhang H, Pan Q, Liu Z, Pan H, Xue L, Yen Y, Chu PG.
    Carcinogenesis; 2015 Feb 01; 36(2):232-42. PubMed ID: 25542894
    [Abstract] [Full Text] [Related]

  • 16. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS, Su ZR, Lee YP, Liu IT, Yen CJ.
    World J Gastroenterol; 2016 Jun 14; 22(22):5183-92. PubMed ID: 27298561
    [Abstract] [Full Text] [Related]

  • 17. HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy.
    Hosaka T, Suzuki F, Kobayashi M, Hirakawa M, Kawamura Y, Yatsuji H, Sezaki H, Akuta N, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Kobayashi M, Kumada H.
    Liver Int; 2010 Nov 14; 30(10):1461-70. PubMed ID: 20840396
    [Abstract] [Full Text] [Related]

  • 18. Differentially expressed genes associated with hepatitis B virus HBx and MHBs protein function in hepatocellular carcinoma.
    Kim DG.
    Methods Mol Biol; 2006 Nov 14; 317():141-55. PubMed ID: 16264227
    [Abstract] [Full Text] [Related]

  • 19. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
    Yoon SY, Kim JM, Oh JH, Jeon YJ, Lee DS, Kim JH, Choi JY, Ahn BM, Kim S, Yoo HS, Kim YS, Kim NS.
    Int J Oncol; 2006 Aug 14; 29(2):315-27. PubMed ID: 16820872
    [Abstract] [Full Text] [Related]

  • 20. [Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells].
    Li BD, Zhao QC, Zhu YT, Zhang FQ, Dou KF.
    Zhonghua Wai Ke Za Zhi; 2006 Apr 01; 44(7):458-62. PubMed ID: 16772080
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 30.